Functional Innovation and Application Research of Domestic Advanced Low-Dose DSA/CT-DSA
Enhancing CBCT-Guided Lung Nodule Puncture Efficiency With Generative AI
1 other identifier
interventional
220
1 country
3
Brief Summary
The goal of this clinical trial is to learn if Generative AI Based Puncture Surgery Navigation System (GPS) can guide lung puncture in adults better. It will also learn about the quality improvement of cone beam CT (CBCT) by GPS. The main questions it aims to answer are:
- Does GPS lower the number of punctures, radiation dose, and complications of participants undergo percutaneous lung puncture?
- Does GPS improve the quality of CBCT images? Researchers will compare GPS to a conventional CBCT guided percutaneous lung puncture to see if GPS can improve the efficacy of lung puncture. Participants will:
- Take the percutaneous lung puncture by the guidance of GPS or conventional CBCT (placebo)
- The number of punctures, the success rate of the procedure, the radiation dose, intraoperative complications and postoperative complications at 7 days will be recorded
- The images of CBCT will be collected
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2025
Shorter than P25 for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 15, 2024
CompletedStudy Start
First participant enrolled
January 1, 2025
CompletedFirst Posted
Study publicly available on registry
January 7, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 18, 2025
CompletedJuly 23, 2025
July 1, 2025
3 months
December 15, 2024
July 17, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of puncture needles of participants for GPS and CBCT-guided lung puncture procedures.
The number of punctures was defined as the number of punctures performed throughout the percutaneous lung puncture procedure.
From enrollment to the end of the lung puncture procedure.
Secondary Outcomes (3)
Radiation dose for GPS and CBCT-guided lung puncture procedures.
From enrollment to the end of the lung puncture procedure.
Puncture time for GPS and CBCT-guided lung puncture procedures.
From enrollment to the end of the lung puncture procedure.
Intraoperative and postoperative complications of participants for GPS and CBCT-guided lung puncture procedures.
From enrollment to the end of the lung puncture procedure at 1 week.
Other Outcomes (3)
Algorithmic performance (peak signal-to-noise ratio)
Through study completion, an average of three months.
Algorithmic performance (structural similarity)
Through study completion, an average of 3 months.
Doctors' scoring of image and lesion quality
Through study completion, an average of 3 months.
Study Arms (2)
GPS guided lung puncture
EXPERIMENTALParticipants will receive percutaneous lung puncture under the guidance of GPS.
CBCT guided lung puncture
PLACEBO COMPARATORParticipants will receive percutaneous lung puncture under the guidance of cone beam CT.
Interventions
Participants will receive percutaneous lung puncture under the guidance of GPS.
Participants will receive percutaneous lung puncture under the guidance of cone beam CT.
Eligibility Criteria
You may qualify if:
- Participants who require CBCT-guided precutaneous lung puncture (PLP) and meet the clinical indications for the procedure.
- Participants with pre-operation CT images available.
- Participants whose physical condition is suitable for PLP.
You may not qualify if:
- Participants have metallic implants in the body, which severely affects the image quality.
- Participants with a history of allergy or serious adverse reactions to iodine contrast media or other related drugs.
- Participants are pregnant or breastfeeding.
- Participants are unwilling or unable to sign informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Wuhan Union Hospital
Wuhan, Hubei, 430022, China
Wuhan Union Jinyinhu Hospital
Wuhan, Hubei, 430022, China
Wuhan Union West Hospital
Wuhan, Hubei, 430022, China
Related Publications (6)
Deng L, Ji Y, Huang S, Yang X, Wang J. Synthetic CT generation from CBCT using double-chain-CycleGAN. Comput Biol Med. 2023 Jul;161:106889. doi: 10.1016/j.compbiomed.2023.106889. Epub 2023 Apr 3.
PMID: 37244147RESULTRen Q, Zhou Y, Yan M, Zheng C, Zhou G, Xia X. Imaging-guided percutaneous transthoracic needle biopsy of nodules in the lung base: fluoroscopy CT versus cone-beam CT. Clin Radiol. 2022 May;77(5):e394-e399. doi: 10.1016/j.crad.2022.02.005. Epub 2022 Feb 25.
PMID: 35227506RESULTChoo JY, Park CM, Lee NK, Lee SM, Lee HJ, Goo JM. Percutaneous transthoracic needle biopsy of small (</= 1 cm) lung nodules under C-arm cone-beam CT virtual navigation guidance. Eur Radiol. 2013 Mar;23(3):712-9. doi: 10.1007/s00330-012-2644-6. Epub 2012 Sep 14.
PMID: 22976917RESULTRotolo N, Floridi C, Imperatori A, Fontana F, Ierardi AM, Mangini M, Arlant V, De Marchi G, Novario R, Dominioni L, Fugazzola C, Carrafiello G. Comparison of cone-beam CT-guided and CT fluoroscopy-guided transthoracic needle biopsy of lung nodules. Eur Radiol. 2016 Feb;26(2):381-9. doi: 10.1007/s00330-015-3861-6. Epub 2015 Jun 6.
PMID: 26045345RESULTSteiling K, Kathuria H, Echieh CP, Ost DE, Rivera MP, Begnaud A, Celedon JC, Charlot M, Dietrick F, Duma N, Fong KM, Ford JG, Gould MK, Holguin F, Perez-Stable EJ, Tanner NT, Thomson CC, Wiener RS, Wisnivesky J. Research Priorities for Interventions to Address Health Disparities in Lung Nodule Management: An Official American Thoracic Society Research Statement. Am J Respir Crit Care Med. 2023 Mar 15;207(6):e31-e46. doi: 10.1164/rccm.202212-2216ST.
PMID: 36920066RESULTMazzone PJ, Lam L. Evaluating the Patient With a Pulmonary Nodule: A Review. JAMA. 2022 Jan 18;327(3):264-273. doi: 10.1001/jama.2021.24287.
PMID: 35040882RESULT
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 15, 2024
First Posted
January 7, 2025
Study Start
January 1, 2025
Primary Completion
March 31, 2025
Study Completion
June 18, 2025
Last Updated
July 23, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share